Front Page News

Novartis Gene Therapies SMA Community Update

October 5, 2023
Posted in ,

Dear SMA Community, It was a pleasure to be able to join so many of you at the Cure SMA Annual Conference in Orlando this […]

Read More ›

Cure SMA on Capitol Hill – A Message from Allie Williams

October 4, 2023
Posted in ,

Hey, it’s Allie here from Oklahoma! I am privileged to serve on the Cure SMA Adult Advisory Council and am part of a group of […]

Read More ›

SMA Highlights and Updates from Biogen

October 2, 2023
Posted in ,

Dear SMA Community, As we reflect on SMA Awareness Month, we take this opportunity to celebrate all those who are a part of the SMA […]

Read More ›

Identifying Biomarkers of Spinal Muscular Atrophy for Further Development

September 28, 2023
Posted in ,

An important part of Cure SMA’s core mission is to carry out and support research that will improve the quality of life for all people […]

Read More ›

NMD Pharma Initiates Phase II Trial for SMA

September 26, 2023
Posted in , ,

NMD Pharma, a clinical-stage biotech company leading the development of novel first-in-class therapies for severe neuromuscular disorders, recently announced that the first SMA patient has […]

Read More ›

Scholar Rock Announces Completion of Enrollment for the Phase 3 SAPPHIRE Trial

September 19, 2023
Posted in , ,

Today, Scholar Rock announced that enrollment in their Phase 3 SAPPHIRE trial is now complete. The Phase 3 trial will evaluate the safety and efficacy of […]

Read More ›

Biohaven Completes Enrollment in Pivotal Phase 3 Study

September 19, 2023
Posted in , , ,

Recently, Biohaven released a statement on the completed enrollment of their pivotal Phase 3 Study of Taldefgrobep Alfa in people with SMA. Check out Biohaven’s […]

Read More ›

Clinical Research and Drug Development Session Highlights from 2023 SMA Research & Clinical Care Meeting

August 7, 2023
Posted in , ,

At the end of June, SMA researchers and clinicians from around the world met in Orlando, Florida, for the 2023 Annual SMA Research & Clinical […]

Read More ›

Genentech Releases SMA Community Letter

August 4, 2023
Posted in ,

Genentech recently issued an SMA community statement highlighting updates from the 2023 SMA Research & Clinical Care Meeting. These updates included: Investigating risdiplam treatment post […]

Read More ›

Thank You for an Amazing 2023 Annual SMA Conference!

July 24, 2023
Posted in , ,

Thank you to everyone who attended the 2023 Annual SMA Conference at Disney’s Yacht & Beach Club in Orlando, Florida! It was an impactful weekend […]

Read More ›
Scroll to Top